# Bristol-Myers Squibb Company (BMY) — Q1-2011 Earnings Results

**Report date:** 2011-04-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2011

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 0.04%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.58 | N/A | +10.06% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management conveyed a cautiously optimistic outlook, emphasizing the potential of their product pipeline. They are confident about future launches but acknowledged ongoing market challenges.

**Key quotes:**

> Management highlighted the strength of their pipeline.

> They expressed confidence in upcoming product launches.

> Focus remains on long-term growth despite current market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a positive surprise in EPS, which contributed to a slight increase in stock price. The management's focus on their product pipeline suggests potential growth opportunities ahead. However, the lack of revenue data and guidance leaves some uncertainty for investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2011_